Literature DB >> 15958367

Long term outcome after intracoronary beta radiation therapy.

G Sianos1, A Hoye, F Saia, W van der Giessen, P Lemos, P J de Feyter, P C Levendag, R van Domburg, P W Serruys.   

Abstract

OBJECTIVES: To determine the long term outcome after intracoronary beta radiation therapy (IRT).
SETTING: Tertiary referral centre.
METHODS: The rate of major adverse cardiac events (MACE) was retrospectively determined in 301 consecutive patients who were treated with IRT. MACE was defined as death, myocardial infarction, or any reintervention. Long term clinical outcome was obtained from an electronic database of hospital records and from questionnaires to the patients and referring physicians. Long term survival status was assessed by written inquiries to the municipal civil registries.
RESULTS: The mean (SD) follow up was 3.6 (1.2) years. The cumulative incidence of MACE at six months was 19.1%, at one year 36.4%, and at four years 58.3%. The target lesion revascularisation (TLR) rate at six months was 12.9%, at one year 28.3%, and at four years 50.4%. From multivariate analysis, dose < 18 Gy was the most significant predictor of TLR. At four years the cumulative incidence of death was 3.8%, of myocardial infarction 13.4%, and of coronary artery bypass surgery 11.3%. Total vessel occlusion was documented in 12.3% of the patients.
CONCLUSIONS: In the long term follow up of patients after IRT, there are increased adverse cardiac events beyond the first six months.

Entities:  

Mesh:

Year:  2005        PMID: 15958367      PMCID: PMC1769013          DOI: 10.1136/hrt.2004.038026

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  25 in total

1.  Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries.

Authors:  Takeshi Kimura; Kenichi Abe; Satoshi Shizuta; Keita Odashiro; Yoshinori Yoshida; Koyu Sakai; Kazuaki Kaitani; Katsumi Inoue; Yoshihisa Nakagawa; Hiroyoshi Yokoi; Masashi Iwabuchi; Naoya Hamasaki; Hideyuki Nosaka; Masakiyo Nobuyoshi
Journal:  Circulation       Date:  2002-06-25       Impact factor: 29.690

2.  Five-year clinical follow-up after intracoronary radiation: results of a randomized clinical trial.

Authors:  Mark A Grise; Vincent Massullo; Shirish Jani; Jeffrey J Popma; Robert J Russo; Richard A Schatz; Erminia M Guarneri; Stephen Steuterman; David A Cloutier; Martin B Leon; Prabhakar Tripuraneni; Paul S Teirstein
Journal:  Circulation       Date:  2002-06-11       Impact factor: 29.690

3.  Long-term effects of intracoronary beta-radiation in balloon- and stent-injured porcine coronary arteries.

Authors:  G L Kałuza; A E Raizner; W Mazur; D G Schulz; J M Buergler; L F Fajardo; F O Tio; N M Ali
Journal:  Circulation       Date:  2001-04-24       Impact factor: 29.690

4.  Intracoronary radiation therapy improves the clinical and angiographic outcomes of diffuse in-stent restenotic lesions: results of the Washington Radiation for In-Stent Restenosis Trial for Long Lesions (Long WRIST) Studies.

Authors:  Ron Waksman; Edouard Cheneau; Andrew E Ajani; R Larry White; Ellen Pinnow; Rebecca Torguson; Regina Deible; Lowell F Satler; Augusto D Pichard; Kenneth M Kent; Paul S Teirstein; Joseph Lindsay
Journal:  Circulation       Date:  2003-03-24       Impact factor: 29.690

5.  Three-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis. Original WRIST. Washington Radiation for In-Stent Restenosis Trial.

Authors:  A E Ajani; R Waksman; A K Sharma; D H Cha; E Cheneau; R L White; D Canos; A D Pichard; L F Satler; K M Kent; E Pinnow; J Lindsay
Journal:  Cardiovasc Radiat Med       Date:  2001 Oct-Dec

6.  Twelve versus six months of clopidogrel to reduce major cardiac events in patients undergoing gamma-radiation therapy for in-stent restenosis: Washington Radiation for In-Stent restenosis Trial (WRIST) 12 versus WRIST PLUS.

Authors:  Ron Waksman; Andrew E Ajani; Ellen Pinnow; Edouard Cheneau; Laurent Leborgne; Regina Dieble; Anh B Bui; Lowell F Satler; Augusto D Pichard; Kenneth K Kent; Joseph Lindsay
Journal:  Circulation       Date:  2002-08-13       Impact factor: 29.690

7.  Five-year clinical and angiographic follow-up after intracoronary iridium-192 radiation therapy.

Authors:  Jose A Condado; Ron Waksman; Jorge F Saucedo; Balram Bhargava; Alexandra J Lansky; Carlos Calderas; Orlando Gurdiel; Juan Gonzalez; Merche Fadoul; Bogart Parra; Isabel Iturria; Bingen Amezaga
Journal:  Cardiovasc Radiat Med       Date:  2002 Apr-Jun

8.  Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up.

Authors:  Muzaffer Degertekin; Patrick W Serruys; David P Foley; Kengo Tanabe; Evelyn Regar; Jeroen Vos; Peter C Smits; Wim J van der Giessen; Marcel van den Brand; Pim de Feyter; Jeffrey J Popma
Journal:  Circulation       Date:  2002-09-24       Impact factor: 29.690

9.  Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis.

Authors:  Jeffrey J Popma; Mohan Suntharalingam; Alexandra J Lansky; Richard R Heuser; Burton Speiser; Paul S Teirstein; Vincent Massullo; Theodore Bass; Randall Henderson; Sigmund Silber; Peter von Rottkay; Raoul Bonan; Kalon K L Ho; Alison Osattin; Richard E Kuntz
Journal:  Circulation       Date:  2002-08-27       Impact factor: 29.690

10.  Intracoronary beta-radiation to reduce restenosis after balloon angioplasty and stenting; the Beta Radiation In Europe (BRIE) study.

Authors:  P W Serruys; G Sianos; W van der Giessen; H J R M Bonnier; P Urban; W Wijns; E Benit; M Vandormael; R Dörr; C Disco; N Debbas; S Silber
Journal:  Eur Heart J       Date:  2002-09       Impact factor: 29.983

View more
  1 in total

1.  Two decades after coronary radiation therapy: A single center longitudinal clinical study.

Authors:  Sumant P Radhoe; Anne-Sophie Schuurman; Jurgen M Ligthart; Karen Witberg; Peter P T de Jaegere; Ron T van Domburg; Evelyn Regar
Journal:  Catheter Cardiovasc Interv       Date:  2019-12-02       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.